Full-Time
Clinical Dietitian
Tenet Healthcare
10,001+ employees
Operates hospitals and clinics; revenue cycle
No salary listed
Detroit, MI, USA
In Person
 Medical, Clinical & Veterinary (1) |
|---|
Get referred to Tenet Healthcare
Find people who can refer or advise you
- Bachelors degree in Nutrition/Dietetics.
- Dietetic Internship in healthcare setting or completion of a supervised practice program at a health care facility, community agency, or a foodservice corporation, or combined with graduate or undergraduate studies. Programs are usually 6 to 12 months in length.
- Registration with the Academy of Nutrition and Dietetics or registry eligible passing the registry exam within 6 months of completion of internship.
- Registration with the Academy of Nutrition and Dietetics required if working with patients with inherited metabolic disorders.
- Performs as a resource person for hospital personnel and medical staff regarding nutrition and participates in multidisciplinary rounds as well as providing education to various departments on nutrition related topics.
- Researches and develops programs for dietetic interns. Participants in the education of dietetic interns by providing specialized and general nutrition instruction.
- Participate in research projects and nutrition related programs.
- Works with outside agencies in obtaining ongoing assistance for patients as appropriate.
- Maintains hospital and departmental policies, procedures, objectives, process improvement and provides input on improving processes and ways to provide high quality patient care.
- Inventory and order office and tube feeding supplies.
- Monitors and directs foodservice personnel to ensure provisions of optimal nutritional food service to patients are met; follows up with patient to ensure adherence to dietary regimen.
- Formulates special recipes or plans to meet the specific needs of patients.
- Promotes guest relations. Maintains good customer service providing assistance to customers in a quick and courteous manner.
- Promotes the value of the DMC by demonstrating behaviors supportive of a commitment to quality, community welfare, respect and involvement, teamwork, open and effective communication, innovation and education, and efficient and effective resource use.
Tenet Healthcare operates a large network of hospitals and outpatient facilities across the United States, including 65 hospitals and about 500 other centers such as surgical hospitals, urgent care sites, and imaging centers. It also owns Conifer Health Solutions, which provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients, helping them manage billing and payments and improve patient outcomes. The company earns revenue mainly from patient services and from Conifer’s administrative and financial services. Its goal is to deliver the right care, in the right place, at the right time, while improving patient outcomes and operational efficiency and serving as a trusted employer and partner.
Company Size
10,001+
Company Stage
IPO
Headquarters
Dallas, Texas
Founded
1967
Get referred to Tenet Healthcare
Find people who can refer or advise you
Simplify's Take
What believers are saying
- USPI delivered $484M Q1 2026 EBITDA, up 6.1% YoY, driven by double-digit outpatient joint replacement growth.
- $1.9B Conifer acquisition secures $1.9B in annual installments over three years from CommonSpirit Health.
- Ambulatory segment targets $2.13B–$2.23B EBITDA in 2026, reinforcing strategic pivot from inpatient to outpatient care.
What critics are saying
- $10.5M legal demand against Leapfrog risks protracted appeal and reputational backlash eroding trust in Florida hospitals.
- Continued insider selling by directors signals weak internal confidence and may accelerate downward stock pressure within 3–6 months.
- Debt-to-equity ratio of 1.96 exposes Tenet to liquidity crunch if interest rates rise in 2026–2027 amid utilization dips.
What makes Tenet Healthcare unique
- Tenet uniquely owns both hospitals and USPI, the nation's largest ASC operator with 533 facilities.
- Full ownership of Conifer Health Solutions enables direct integration of revenue cycle management with clinical operations.
- Dual-platform model captures the industry shift toward lower-cost outpatient care while maintaining complex inpatient services.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Professional Development Budget
Mental Health Support
Paid Sick Leave
Paid Holidays
Paid Vacation
Health Insurance
Flexible Work Hours
Company News
HCA Florida Woodmont Hospital names Robby Payne as chief financial officer. Payne brings more than a decade of healthcare finance and operations leadership experience to HCA Florida Woodmont Hospital, most recently serving as regional chief financial officer for Tenet Healthcare's North Texas market, where he oversaw financial operations for two hospitals and five ambulatory surgery centers. June 30, 2026 HCA Florida Woodmont Hospital has appointed Robby Payne as chief financial officer (CFO). Payne joins HCA Florida Woodmont Hospital with more than a decade of healthcare finance and operations leadership experience. He most recently served as regional chief financial officer for Tenet Healthcare's North Texas market, where he oversaw financial operations for two hospitals and five ambulatory surgery centers and supported strategic growth initiatives across a diverse healthcare portfolio. Prior to his regional leadership role, Payne served as chief financial officer and acting chief operating officer at Baylor Medical Center-Trophy Club near Dallas, Texas. During his tenure, he led initiatives that enhanced financial performance, supported operational improvements and helped secure approval for significant capital investments that strengthened the hospital's infrastructure and long-term growth. Earlier in his career, Robby held finance leadership positions with Community Health Systems, including assistant chief financial officer, and served as hospital controller at Pinewood Springs, an HCA Healthcare-affiliated facility. Payne earned a master's degree in business administration with a concentration in finance from Belmont University and a bachelor's degree in economics and finance from Middle Tennessee State University. Published: June 29, 2026 HCA Florida Woodmont Hospital Related newsroom articles. June 30, 2026 Alexis Bustamante, MSHRM, PHR, has been named vice president of human resources at HCA Florida Woodmont Hospital, bringing experience in colleague engagement, leadership development and workforce strategy from her previous role at HCA Florida Aventura Hospital. May 08, 2026 The nurses partnered with Harvest Drive Florida, reinforcing their commitment to compassionate care beyond the hospital through hands-on service supporting local families. May 07, 2026 Caren Roach, chief nursing officer at HCA Florida Woodmont Hospital, brings over 20 years of healthcare experience and a strong track record in patient-centered leadership, operational excellence, and continuous improvement to the Broward County facility.
Tenet's expansion into Conifer and outpatient growth: The true driver of earnings overlooked amid insider selling distractions. By: 101 finance Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now! Insider activity and leadership changes: context for Tenet Healthcare. Recent developments at Tenet Healthcare have drawn attention, particularly regarding insider transactions and changes in leadership. Paola Arbour, the company's Chief Information Officer, sold 18,168 shares in March 2024, bringing her total sales over the past year to 56,724 shares, with no corresponding purchases. This activity followed the departure of board member Stephen H. Rusckowski in November 2025. These events together highlight a trend of insider selling and boardroom turnover. For investors, the main question is whether these actions are significant indicators or simply background noise. The market has had time to process both the executive's share sales and the board change, with the CIO's transactions occurring more than a year ago and the board resignation announced last fall. During this period, Tenet has been undergoing a substantial strategic transformation, including the $2.4 billion divestiture of three South Carolina hospitals in early 2024 as part of a broader shift in its business portfolio. The company has also rapidly expanded its ambulatory care network, adding more than 50 new surgery centers within a year. Given these broader changes, market sentiment appears to be focused on Tenet's strategic direction rather than individual leadership exits. The company's recent price-to-earnings ratio of 17.28, which is below the sector median, suggests that investors are prioritizing operational execution and business transformation over management turnover. While insider selling is noteworthy, it may simply reflect routine financial planning or diversification by a long-serving executive, especially in the context of a company actively reinventing itself. Ultimately, expectations are being shaped by Tenet's strategic initiatives. The company's share price likely already factors in the reality of ongoing transformation. The real challenge lies not in executive departures, but in whether Tenet can continue to deliver on its ambitious plans. So far, the market seems to have absorbed the impact of leadership changes into the larger narrative of corporate evolution. Strategic portfolio realignment: the main value catalyst. While much attention has been paid to changes in Tenet's leadership, the real story lies in the company's disciplined approach to capital allocation and business restructuring. The major transactions completed in 2024 and 2026 are part of a cohesive strategy to strengthen Tenet's hospital and ambulatory platforms by divesting lower-margin assets and regaining control of essential services. * 2024 Hospital Sale: The $2.4 billion sale of three South Carolina hospitals to Novant Health marked a pivotal step in Tenet's transformation, as the company divested a total of 14 hospitals that year. The transaction provided a substantial cash boost to reduce debt and strengthen the balance sheet, despite resulting in a $222 million annual EBITDA reduction. The trade-off was considered worthwhile for the increased financial flexibility and streamlined operations. * 2026 Conifer Acquisition: In early 2026, Tenet finalized an agreement with CommonSpirit Health to acquire full ownership of Conifer Health Solutions. This $1.9 billion deal, which included payments and a capital redemption, eliminated a redeemable non-controlling interest and $885 million in liabilities. Gaining full control of Conifer enables Tenet to better integrate revenue cycle management with its operational objectives and invest in future growth. These strategic moves have fueled Tenet's expansion in ambulatory care. By the end of 2024, its United Surgical Partners International subsidiary had grown from 461 to 518 ambulatory surgery centers, adding 57 new facilities in just one year. This shift from traditional hospital operations to higher-margin outpatient care is the primary driver of value. Leadership changes, in this context, are secondary to the company's fundamental transformation, which is already reflected in its market valuation. Strategy spotlight: absolute momentum long-only approach. Tenet's stock performance has also been analyzed using a long-only absolute momentum strategy. This approach involves entering positions when the 252-day rate of change is positive and the closing price is above the 200-day simple moving average, and exiting when the price falls below the 200-day average, after 20 trading days, or upon reaching a take-profit of 8% or a stop-loss of 4%. The backtest, covering April 2024 to April 2026, yielded the following results: * Total Return: 26.91% * Annualized Return: 15.07% * Maximum Drawdown: 17.81% * Profit-Loss Ratio: 1.43 * Win Rate: 47.83% (11 wins out of 23 trades) * Average Holding Period: 8.87 days Financial performance and earnings outlook. Tenet's investment appeal is closely tied to its ability to deliver on financial targets. The company has a history of meeting or exceeding its own guidance, as demonstrated in January 2023 when it announced it would surpass the midpoint of its FY22 Adjusted EBITDA forecast. This track record of operational discipline is now under scrutiny as Tenet works to translate its strategic changes into sustainable earnings growth. The upcoming earnings report on April 30 will be a critical milestone, offering the first comprehensive look at the financial impact of the 2024 hospital divestitures and the 2026 Conifer acquisition. Investors will be watching to see if the rapid expansion of ambulatory services is beginning to offset the EBITDA lost from hospital sales and drive top-line growth. The market will be looking for evidence that Tenet can maintain its momentum as it pivots toward outpatient care. This sets up a classic risk/reward scenario. While the company's strategic moves are already priced into the stock, the true test will be Tenet's ability to convert its growing ambulatory platform and prudent capital management into consistent earnings growth. With the stock trading below the industry median, any failure to meet or exceed expectations could prompt a market reassessment. For now, Tenet is viewed as a capable operator meeting high expectations, but the upcoming earnings release will be a key indicator of whether it can sustain this performance. Key catalysts and risks: beyond executive departures. Looking ahead, Tenet's outlook is shaped by two main factors: a significant financial catalyst and ongoing governance risks. The most immediate catalyst is the execution of the Conifer transaction, which is structured as a multi-year arrangement. The deal, completed in early 2026, involves approximately $1.9 billion in payments from CommonSpirit to Tenet over three years. While this provides a steady cash flow, the real challenge will be how effectively management uses these funds to support further ambulatory expansion and reduce debt, ultimately driving sustained earnings growth. However, the ongoing pattern of insider selling remains a concern. Over the past year, there have been seven insider sales and no insider purchases, which could be interpreted as a lack of internal confidence. While the CIO's sales are not recent, continued insider selling or further leadership changes could raise questions about the company's strategic direction and financial health, potentially testing the market's current optimism. Ultimately, Tenet's future performance will depend on its ability to deliver sustained earnings growth as it scales its outpatient business and manages its substantial debt. The Conifer payments provide a financial buffer, but operational excellence remains essential. The upcoming earnings report will offer crucial insight into how these strategic initiatives are affecting the bottom line. In this environment, the impact of individual executive departures is overshadowed by the tangible financial outcomes of Tenet's multi-year transformation and the ongoing question of whether insider selling signals deeper concerns. Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Guggenheim has raised its price target on Tenet Healthcare Corporation from $271 to $283, maintaining a Buy rating on the stock. The firm cited the company's 90% return and described the first quarter as an "easy set-up" due to conservative guidance. It also views the projected 10% core EBITDA growth for 2026 as achievable. On the same day, Mizuho increased its price target from $235 to $265, maintaining an Outperform rating. The firm expects Tenet Healthcare to benefit from demographic shifts toward an ageing population and a focus on higher-acuity surgeries. Founded in 1969, Tenet Healthcare is a Texas-based diversified healthcare services company operating through Hospital Operations and Ambulatory Care segments.
Tenet Healthcare Corporation has received positive analyst coverage following its fourth-quarter earnings release. Truist raised its price target to $270 from $240 on 17 February, maintaining a Buy rating after adjusting its model based on the company's fiscal Q4 results and 2026 guidance. Wells Fargo also increased its target to $265 from $229 on 16 February, keeping an Overweight rating. The firm cited strong capital return potential and market narrative alignment as key drivers, despite surprise at the stock's movement on previewed EBITDA figures. Tenet Healthcare reported Q4 net income of $371 million, or $4.22 per diluted share. Adjusted diluted earnings per share rose 36.6% to $4.70 compared to $3.44 in the previous year. The company operates through Hospital Operations and Ambulatory Care segments.
Tenet Healthcare has regained full ownership of its revenue cycle management subsidiary Conifer Health Solutions after CommonSpirit Health exited its stake. CommonSpirit will pay Tenet nearly $1.9 billion over three years to exit its services contract, offset by $540 million that Conifer will pay for CommonSpirit's 24% equity stake. The deal creates approximately $2.7 billion in total value for Tenet through cash payments, reduced balance sheet liability and additional equity value. Tenet's stock rose 2% following the announcement. Conifer processes roughly $25 billion in net patient revenue annually for over 600 clients. As sole owner, Tenet plans to increase investments in Conifer's artificial intelligence and automation capabilities, particularly in claims processing and managing disputes with insurers over claim denials.